Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

2.

The effect of surgical consult in the treatment of abdominal pain in older adults in the ED.

Roberts ES, Belland L, Rivera-Reyes L, Hwang U.

Am J Emerg Med. 2016 Aug;34(8):1524-7. doi: 10.1016/j.ajem.2016.05.010. Epub 2016 May 11.

3.

Confirmatory field study for the evaluation of ciclosporin at a target dose of 7.0 mg/kg (3.2 mg/lb) in the control of feline hypersensitivity dermatitis.

Roberts ES, Speranza C, Friberg C, Griffin C, Steffan J, Roycroft L, King S.

J Feline Med Surg. 2016 Nov;18(11):889-897. doi: 10.1177/1098612X16636660. Epub 2016 Jul 9.

PMID:
26965676
4.

Clinical efficacy and safety following dose tapering of ciclosporin in cats with hypersensitivity dermatitis.

Roberts ES, Tapp T, Trimmer A, Roycroft L, King S.

J Feline Med Surg. 2016 Nov;18(11):898-905. doi: 10.1177/1098612X15602523. Epub 2016 Jul 9.

PMID:
26316515
5.

Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial.

King JN, King S, Budsberg SC, Lascelles BD, Bienhoff SE, Roycroft LM, Roberts ES.

J Feline Med Surg. 2016 Aug;18(8):632-42. doi: 10.1177/1098612X15590870. Epub 2015 Jun 9.

PMID:
26058587
6.

Effect of oral administration of cyclosporine on Toxoplasma gondii infection status of cats.

Lappin MR, VanLare KA, Seewald W, Roycroft LM, Scorza AV, King S, Roberts ES.

Am J Vet Res. 2015 Apr;76(4):351-7. doi: 10.2460/ajvr.76.4.351.

PMID:
25815576
7.

Effect of high-dose ciclosporin on the immune response to primary and booster vaccination in immunocompetent cats.

Roberts ES, VanLare KA, Roycroft LM, King S.

J Feline Med Surg. 2015 Feb;17(2):101-9. doi: 10.1177/1098612X14533550. Epub 2014 May 12.

PMID:
24820998
8.

Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.

Roberts ES, Vanlare KA, Strehlau G, Peyrou M, Roycroft LM, King S.

J Vet Pharmacol Ther. 2014 Apr;37(2):161-8. doi: 10.1111/jvp.12081. Epub 2013 Oct 18.

9.

Atrial fibrillation detected after acute ischemic stroke: evidence supporting the neurogenic hypothesis.

González Toledo ME, Klein FR, Riccio PM, Cassará FP, Muñoz Giacomelli F, Racosta JM, Roberts ES, Sposato LA.

J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e486-91. doi: 10.1016/j.jstrokecerebrovasdis.2013.05.015. Epub 2013 Jun 22.

PMID:
23800494
10.

Impact of temperature stress and validamycin A on compatible solutes and fumonisin production in F. verticillioides: role of trehalose-6-phosphate synthase.

Boudreau BA, Larson TM, Brown DW, Busman M, Roberts ES, Kendra DF, McQuade KL.

Fungal Genet Biol. 2013 Aug;57:1-10. doi: 10.1016/j.fgb.2013.06.001. Epub 2013 Jun 7.

PMID:
23751979
11.

Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA: hypothetical implications.

Riccio PM, Klein FR, Pagani Cassará F, Muñoz Giacomelli F, González Toledo ME, Racosta JM, Delfitto M, Roberts ES, Bahit MC, Sposato LA.

Neurology. 2013 May 14;80(20):1834-40. doi: 10.1212/WNL.0b013e318292a330. Epub 2013 Apr 17.

PMID:
23596075
12.

The spatial relationship between neurons and astrocytes in HIV-associated dementia.

Roberts ES, Chana G, Nguyen TB, Perera G, Landau S, Rabe-Hesketh S, Glass JD, McArthur J, Everall IP.

J Neurovirol. 2013 Apr;19(2):123-30. doi: 10.1007/s13365-013-0149-y. Epub 2013 Feb 21.

PMID:
23430713
13.

Efficacy of a single oral administration of milbemycin oxime against natural infections of Ancylostoma braziliense in dogs.

Bienhoff SE, Kok DJ, Roycroft LM, Roberts ES.

Vet Parasitol. 2013 Jul 1;195(1-2):102-5. doi: 10.1016/j.vetpar.2013.01.004. Epub 2013 Jan 16.

14.

Unbiased degree-preserving randomization of directed binary networks.

Roberts ES, Coolen AC.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Apr;85(4 Pt 2):046103. Epub 2012 Apr 5.

PMID:
22680534
15.

Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs.

Bienhoff SE, Smith ES, Roycroft LM, Roberts ES.

Vet Surg. 2012 Apr;41(3):336-44. doi: 10.1111/j.1532-950X.2011.00942.x. Epub 2012 Jan 6.

PMID:
22225463
16.

Development of environmental thresholds for streams in agricultural watersheds.

Chambers PA, Culp JM, Roberts ES, Bowerman M.

J Environ Qual. 2012 Jan-Feb;41(1):1-6. doi: 10.2134/jeq2011.0338.

PMID:
22218168
17.

Evaluation of oral robenacoxib for the treatment of postoperative pain and inflammation in cats: results of a randomized clinical trial.

King S, Roberts ES, Roycroft LM, King JN.

ISRN Vet Sci. 2012 Jul 1;2012:794148. doi: 10.5402/2012/794148. Print 2012.

18.

Efficacy and safety of deracoxib for the control of postoperative pain and inflammation associated with dental surgery in dogs.

Bienhoff SE, Smith ES, Roycroft LM, Roberts ES, Baker LD.

ISRN Vet Sci. 2012 Jan 23;2011:593015. doi: 10.5402/2011/593015. Print 2011.

19.

Safety and tolerability of 3-week and 6-month dosing of Deramaxx (deracoxib) chewable tablets in dogs.

Roberts ES, Van Lare KA, Marable BR, Salminen WF.

J Vet Pharmacol Ther. 2009 Aug;32(4):329-37. doi: 10.1111/j.1365-2885.2008.01043.x.

PMID:
19614837
20.

Gene expression changes following acute hydrogen sulfide (H2S)-induced nasal respiratory epithelial injury.

Roberts ES, Thomas RS, Dorman DC.

Toxicol Pathol. 2008 Jun;36(4):560-7. doi: 10.1177/0192623308317422. Epub 2008 May 8.

PMID:
18467678
21.

In situ pulmonary localization of air pollution particle-induced oxidative stress.

Roberts ES, Malstrom SE, Dreher KL.

J Toxicol Environ Health A. 2007 Nov;70(22):1929-35.

PMID:
17966064
22.

Basal gene expression in male and female Sprague-Dawley rat nasal respiratory and olfactory epithelium.

Roberts ES, Soucy NV, Bonner AM, Page TJ, Thomas RS, Dorman DC.

Inhal Toxicol. 2007 Sep;19(11):941-9.

PMID:
17849278
23.

Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection.

Roberts ES, Huitron-Resendiz S, Taffe MA, Marcondes MC, Flynn CT, Lanigan CM, Hammond JA, Head SR, Henriksen SJ, Fox HS.

J Neurosci. 2006 Apr 26;26(17):4577-85.

24.

What's your diagnosis? Lethargy and hind limb paralysis in a day-23 timed pregnant rat.

Roberts ES, Bonner AM, Everitt JI, Dorman DC.

Lab Anim (NY). 2006 Feb;35(2):19-20. No abstract available.

PMID:
16446732
25.

Changes in intracellular pH play a secondary role in hydrogen sulfide-induced nasal cytotoxicity.

Roberts ES, Wong VA, McManus BE, Marshall MW, Lancianese S, Dorman DC.

Inhal Toxicol. 2006 Mar;18(3):159-67.

PMID:
16399658
26.

Manipulation under anesthesia: a report of four cases.

Cremata E, Collins S, Clauson W, Solinger AB, Roberts ES.

J Manipulative Physiol Ther. 2005 Sep;28(7):526-33.

PMID:
16182028
27.

CD163 identifies a unique population of ramified microglia in HIV encephalitis (HIVE).

Roberts ES, Masliah E, Fox HS.

J Neuropathol Exp Neurol. 2004 Dec;63(12):1255-64.

PMID:
15624762
28.

Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis.

Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS.

J Neuroimmunol. 2004 Dec;157(1-2):163-75. Erratum in: J Neuroimmunol. 2005 May;162(1-2):197.

PMID:
15579294
29.

Acute SIV infection of the brain leads to upregulation of IL6 and interferon-regulated genes: expression patterns throughout disease progression and impact on neuroAIDS.

Roberts ES, Burudi EM, Flynn C, Madden LJ, Roinick KL, Watry DD, Zandonatti MA, Taffe MA, Fox HS.

J Neuroimmunol. 2004 Dec;157(1-2):81-92.

PMID:
15579284
30.

Oxidative stress mediates air pollution particle-induced acute lung injury and molecular pathology.

Roberts ES, Richards JH, Jaskot R, Dreher KL.

Inhal Toxicol. 2003 Nov;15(13):1327-46.

PMID:
14569496
31.

Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS.

Am J Pathol. 2003 Jun;162(6):2041-57.

32.

Mechanistic studies of cytochrome P450 2B1 inactivation by xanthates.

Yanev SG, Kent UM, Roberts ES, Ballou DP, Hollenberg PF.

Arch Biochem Biophys. 2000 Jun 1;378(1):157-66.

PMID:
10871056
33.

Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility.

Strobel SM, Szklarz GD, He Y, Foroozesh M, Alworth WL, Roberts ES, Hollenberg PF, Halpert JR.

J Pharmacol Exp Ther. 1999 Jul;290(1):445-51.

PMID:
10381811
34.

Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.

Kent UM, Roberts ES, Chun J, Hodge K, Juncaj J, Hollenberg PF.

Chem Res Toxicol. 1998 Oct;11(10):1154-61.

PMID:
9778311
35.

Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1.

Roberts ES, Lin Hl, Crowley JR, Vuletich JL, Osawa Y, Hollenberg PF.

Chem Res Toxicol. 1998 Sep;11(9):1067-74.

PMID:
9760281
36.

Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.

Roberts ES, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1998 Jun 15;354(2):295-302.

PMID:
9637739
37.
38.
39.

Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.

Roberts ES, Hopkins NE, Foroozesh M, Alworth WL, Halpert JR, Hollenberg PF.

Drug Metab Dispos. 1997 Nov;25(11):1242-8.

PMID:
9351899
40.

Metabolic inactivation of cytochrome P4502B1 by phencyclidine: immunochemical and radiochemical analyses of the protective effects of glutathione.

Sharma U, Roberts ES, Kent UM, Owens SM, Hollenberg PF.

Drug Metab Dispos. 1997 Feb;25(2):243-50.

PMID:
9029055
41.

Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes.

Beebe LE, Roberts ES, Fornwald LW, Hollenberg PF, Alworth WL.

Biochem Pharmacol. 1996 Nov 22;52(10):1507-13.

PMID:
8937464
42.

Formation of a metabolic intermediate complex of cytochrome P4502B1 by clorgyline.

Sharma U, Roberts ES, Hollenberg PF.

Drug Metab Dispos. 1996 Nov;24(11):1247-53.

PMID:
8937860
43.

A role for threonine 302 in the mechanism-based inactivation of P450 2B4 by 2-ethynylnaphthalene.

Roberts ES, Pernecky SJ, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1996 Jul 15;331(2):170-6.

PMID:
8660695
44.

Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.

Sharma U, Roberts ES, Hollenberg PF.

Drug Metab Dispos. 1996 Jun;24(6):669-75.

PMID:
8781784
45.

Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1.

Roberts ES, Ballou DP, Hopkins NE, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1995 Nov 10;323(2):303-12.

PMID:
7487092
46.

Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.

Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF.

Arch Biochem Biophys. 1995 Nov 10;323(2):295-302.

PMID:
7487091
47.

Identification of active-site peptides from 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry.

Roberts ES, Hopkins NE, Zaluzec EJ, Gage DA, Alworth WL, Hollenberg PF.

Biochemistry. 1994 Mar 29;33(12):3766-71.

PMID:
8142377
48.

Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene: identification of an active-site peptide.

Roberts ES, Hopkins NE, Alworth WL, Hollenberg PF.

Chem Res Toxicol. 1993 Jul-Aug;6(4):470-9.

PMID:
8374044
49.
50.

Supplemental Content

Loading ...
Support Center